NASDAQ:DTIL

Precision Biosciences Stock News

etoro logo Buy DTIL
*Your capital is at risk
$6.04
-0.280 (-4.43%)
At Close: Jun 03, 2026
Precision BioSciences Inc (NASDAQ:DTIL) shares were down 1.5% during trading on Thursday . The company traded as low as $6.56 and last traded at $6.51, approximately 12,064 shares were traded during t
These healthcare stocks are risky, but they offer investors much better wealth-building potential than penny stocks.
Bailard Inc. grew its position in Precision BioSciences Inc (NASDAQ:DTIL) by 66.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commiss
DURHAM, N.C., April 15, 2020 -- Precision BioSciences, Inc. (Nasdaq: DTIL), a life sciences company dedicated to improving life through the application of its pioneering,.
Shares of Precision BioSciences Inc (NASDAQ:DTIL) have been assigned an average recommendation of “Buy” from the eleven brokerages that are currently covering the company, MarketBeat.com reports.
Atara Biotherapeutics recently updated that its lead program, tab-cel, remains on track despite the COVID-19 pandemic. Tab-cel is the most advanced allogeneic T
HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL) in a research report released on Wednesday, AnalystRatings.com reports. HC Wainwright currently has a $19.00
Precision BioSciences Inc (NASDAQ:DTIL)’s stock price shot up 8.6% during trading on Thursday . The stock traded as high as $6.42 and last traded at $6.30, 360,602 shares traded hands during mid-day
Precision BioSciences Inc (NASDAQ:DTIL) – William Blair reduced their FY2022 earnings estimates for shares of Precision BioSciences in a research report issued to clients and investors on Tuesday, A
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic (HOLX) and Precision BioSciences (DTIL) with
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Hologic ( HOLX – Research Report ) and Precision BioSciences ( DTIL – Research Report ) with bullis
Precision BioSciences, Inc. (DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, today announced the init
Precision BioSciences Inc (NASDAQ:DTIL)’s stock price dropped 15.9% on Friday . The stock traded as low as $4.60 and last traded at $4.66, approximately 507,292 shares traded hands during trading. A
Investors worried about a recession like venBio Partners’ risk-mitigated approach to venture capital investing. That approach has led new limited partners
venBio Closes $394 Million Life Sciences Venture Capital Fund, Bringing Total Assets Under Management to Nearly $1 Billion
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE